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Abstract 
Long-term in vivo imaging of cells is crucial for the understanding of cellular fate in biological processes in 
cancer research, immunology or in cell-based therapies such as beta cell transplantation in type I diabetes 
or stem cell therapy. Traditionally, cell labelling with the desired contrast agent occurs ex vivo via 
spontaneous endocytosis, which is a variable and slow process that requires optimization for each particular 
label-cell type combination. Following endocytic uptake, the contrast agents mostly remain entrapped in the 
endolysosomal compartment, which leads to signal instability, cytotoxicity and asymmetric inheritance of 
the labels upon cell division. Here, we demonstrate that these disadvantages can be circumvented by 
delivering contrast agents directly into the cytoplasm via vapour nanobubble photoporation. Compared to 
classic endocytic uptake, photoporation resulted in 50 and 3 times higher loading of fluorescent dextrans 
and quantum dots, respectively, with improved signal stability and reduced cytotoxicity. Most interestingly, 
cytosolic delivery by photoporation prevented asymmetric inheritance of labels by daughter cells over 
subsequent cell generations. Instead, unequal inheritance of endocytosed labels resulted in a dramatic 
increase in polydispersity of the amount of labels per cell with each cell division, hindering accurate 
quantification of cell numbers in vivo over time. The combined benefits of cell labelling by photoporation 
resulted in a marked improvement in long-term cell visibility in vivo where an insulin producing cell line 
(INS-1E cell line) labelled with fluorescent dextrans could be tracked for up to two months in Swiss Nude 
mice compared to two weeks for cells labelled by endocytosis.     
Keywords:  cell labelling, cytosolic delivery, nanoparticle inheritance, vapour nanobubble photoporation,  
in vivo cell tracking, quantum dots  
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Introduction 
There is great interest in monitoring in vivo transplanted cells for research and therapeutic purposes. In 
cancer research, for instance, it is of importance to visualize cancer cells in real time to study their metastatic 
potential in animal models1. In vivo tracking of cells is also desired for cell therapies to follow-up on 
treatment efficacy2. Examples are stem cells in regenerative medicine3, 4, β-cells for the treatment of type I 
diabetes5 and immune cells such as T-cells in immunotherapy6.  
For in vivo cell tracking, the cells need to be labelled before transplantation, for which two main strategies 
are being explored. One is to transfect the cells with a reporter gene2, 7 and follow-up on their proliferation 
through optical imaging, positron emission tomography or magnetic resonance imaging8-10. This strategy, 
however, requires a rather time-consuming transfection procedure that may lead to undesired phenotypical 
alterations and abnormalities in the transplanted cells in comparison to the native cells11-13. The second 
strategy is to label the cells with exogenous contrast agents, being either organic probes or inorganic 
nanoparticles (NPs)14, 15. Examples are fluorescently labelled dextrans16, 17 and quantum dots (QD) for 
optical fluorescence imaging18-20, or superparamagnetic iron oxide NPs and Gadolinium complexes for 
magnetic resonance imaging (MRI)4, 21, 22. Traditionally, these contrast agents are simply incubated with the 
cells, in some cases in combination with transfecting agents, so that they are internalized primarily by 
endocytic uptake. Despite its simplicity and widespread use, several disadvantages are connected to this 
way of labelling cells. First, as endocytosis is a highly cell-type dependent process, the labelling procedure 
needs to be optimized for each particular nanomaterial-cell type combination. In addition, several cell types 
such as T-cells have difficulties in internalizing extracellular compounds through endocytosis23. In other 
cases, problems may arise for cells that have a limited life span in culture, such as pancreatic islets, as 
efficient cell labelling through endocytic uptake is a rather slow process24. A second problem is that 
entrapment of contrast agents in the acidic endolysosomes may lead to increased cytotoxicity, for instance 
by creating reactive groups on the NP surface or by leaching of toxic metal ions, such as Cd2+ in case of 
QDs25-27. A third disadvantage of endocytic cell labelling is that the vast majority of the contrast agents are 
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trafficked to the endolysosomes where they are exposed to an acidic and overall degrading environment26, 
28. This can lead to degradation of the contrast agent, lowering the signal intensity, as reported for fluorescent 
labels28-30 as well as MRI contrast agents31-33. In addition, it has been reported that nanomaterials trapped in 
endolysosomal vesicles are not distributed equally over daughter cells upon cell division30, 34, 35. While this 
process has been proposed to be a protective mechanism where the daughter cell with the highest NP load 
can be sacrificed in favour of the daughter cell with the lowest NP content29, 36, recent findings show that 
asymmetric inheritance of vesicles is an inherent cell-biological phenomenon37. For quantitative cell 
tracking applications asymmetric inheritance of contrast agents over daughter cells is disadvantageous as it 
hinders accurate quantification of cell numbers over time, apart from the fact that the brightest signals are 
coming from cells that are suffering from the highest cytotoxicity.  
In this work, we hypothesized that direct delivery of contrast agents into the cytosol could alleviate the many 
difficulties related to endocytic cell labelling. Evidently, this requires a technology that is able to deliver a 
broad range of contrast agents across the cell membrane in a fast, efficient and non-toxic manner. Vapour 
nanobubble (VNB) photoporation is an interesting and relatively new method that is receiving increasing 
interest in recent years to deliver nanomaterials into cells38-41. It is based on the usage of plasmonic 
nanoparticles, typically gold nanoparticles (AuNP), adsorbed to the plasma membrane of cells that are 
illuminated with pulsed laser light. If a short laser pulse (< 10 ns) of sufficiently high intensity is absorbed 
by an AuNP, its temperature can rapidly increase to several hundred degrees due to efficient heat 
confinement42. If the AuNP is located in hydrated tissue, like in cell culture, the water surrounding the AuNP 
will evaporate. This results in the generation of an expanding VNB around the AuNP surface, with a size 
ranging from tens to hundreds of nm depending on the laser pulse intensity. When the thermal energy of the 
AuNP is consumed, the VNB violently collapses causing local damage to the surrounding tissue by high-
pressure shock waves. Due to the extremely short lifetime of VNBs (<1 µs), the diffusion of heat from the 
AuNP into the environment is negligible so that almost all energy of the irradiated AuNP is converted to 
mechanical energy (expansion of the VNB). This property makes VNB photoporation an interesting 
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technology to mechanically perforate the cell membrane, without causing unspecific thermal damage to 
cells. Building forth on recent successes with the cytosolic delivery of therapeutic molecules43-45, here we 
show that vapour nanobubble photoporation is a well-suited technology for cytosolic cell labelling in a fast 
and non-toxic manner.  First, we demonstrate efficient and safe loading of fluorescent dextran and QD in 
different cell types by photoporation. Compared to endocytic uptake, cell loading with photoporation was 
50 and 3 times more efficient for FITC-dextran (FD) and QD, respectively. Combined with reduced toxicity, 
this enabled extended cell visualization in vitro over 10 generations for FD and 3 generations for QD. This 
shows that old-school labelled dextrans are excellent inexpensive and bio-compatible labels for cell tracking 
when delivered by photoporation as compared to much more expensive and toxic QDs. We demonstrate for 
the first time that asymmetric inheritance of fluorescent labels can be avoided by cytosolic delivery via 
photoporation. As a result, the cell intensity polydispersity remains identical over multiple cell divisions, 
while it rapidly increases for endocytic loading (already factor 10 after 6 divisions). Finally, we show 
extended in vivo imaging of an insulin producing cell line (INS-1E cell line) labelled with Cy5.5-dextran by 
photoporation. Cells labelled by photoporation could be imaged up to two months instead of only two weeks 
in case of endocytic labelling.  
Results 
Photoporation enables efficient cytosolic delivery of contrast agents with reduced cytotoxicity.  
The procedure of delivering contrast agents into the cytosol of cells by vapour nanobubble photoporation is 
illustrated in Fig. 1a. Cells are first incubated with plasmonic NPs, such as gold NPs (AuNPs), for 15-30 
min. During that time the AuNP can adsorb to the cells and  are internalized just below the plasma membrane 
by endocytic uptake (see TEM images in Figure S1). On average ~8 AuNPs are associated per cell as 
determined by confocal reflection imaging (Figure S1 and  Supporting Movie 1). After washing the cells 
to remove the unbound AuNPs, the contrast agent is added and the cells are irradiated with ns (nanosecond) 
pulsed laser light. When a laser pulse of sufficiently high intensity is applied, the temperature of the AuNPs 
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increases to several hundred degrees causing the water surrounding the AuNPs to evaporate.46 This in turn 
results in the formation of vapour nanobubbles that expand and collapse, thereby inducing pores in the cell 
membrane and allowing the contrast agent to diffuse into the cytoplasm. In our set-up, the cells are grown 
in a 96-well plate and the laser beam covers a circular area of ~150 µm diameter. The laser pulses are 
synchronized with a programmed motorized stage to assure that each cell in the culture dish receives one or 
two laser pulse. Scanning of the entire well takes approximately three minutes, which is essentially limited 
by the laser repetition rate (20 Hz). The generation of vapour nanobubbles can be confirmed with dark field 
microscopy (Figure S1c), or in time-resolved transmitted light mode (Figure S1b). To confirm successful 
photoporation of the cell membrane, we in-situ recorded the cytoplasmic accumulation of the cell 
impermeable dye Propidium Iodide (PI) (Supporting Movie 2, Supporting Information). To assess the size 
of VNB induced membrane pores, we measured the delivery efficiency of  FITC-dextran of 10 kDa (FD10), 
150 kDa (FD150) and 500 kDa (FD500), which have a hydrodynamic diameter of respectively 4, 17 and 31 
nm. The photoporation procedure was carried out at 3 different laser fluence settings (1, 2 and 4 J/cm²). It 
is expected that bigger VNB are formed with higher laser fluences, which should result in bigger membrane 
pores as well. The data in Figure S2a and S2b show that all three probes could be delivered into 80-95% 
of the cells although the amount per cell is clearly less for the bigger probes. By increasing the laser fluence 
a slight increase in delivery efficiency was observed, indicative of slightly bigger pores.  Based on FD500 
delivery we conclude that pores created under the illumination conditions used in this study can have a size 
of at least 30 nm diameter. We also tried to estimate the pore lifetime by adding the FITC-dextran probes 
as a function of time after photoporation to the cells. The data in Figure S2c and S2d show that already 
after 1 min most of the cells have been completely resealed considering that only about 25% still show 
uptake of the smallest probe (FD10). And even in those cells the remaining pores must have been very small 
since the amount of FD10 taken up in those cells is about 100 fold less as when the probe is present during 
photoporation. Looking at FD500, there is no more uptake after 1 min, showing that all pores have become 
smaller than 30 nm after 1 min.  After 3 min there is no further influx of any of the probes, indicating that 
all pores are resealed in less than 3 min after photoporation. 
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Since both organic probes and inorganic NPs receive much attention for long-term cell tracking, we selected 
FITC-dextran (FD) and CdSe/ZnS core/shell quantum dot (CdSe QD) as exemplary contrast agents. For 
both labels we performed a systematic comparison between endocytic labelling and cytosolic delivery by 
photoporation in HeLa cells in terms of uptake efficiency and cell viability. Endocytic labelling was 
performed by incubating the cells for 1 h with increasing concentrations of the contrast agent. Note that a 1 
h incubation time was selected since QD induced toxicity became too high for longer incubation times 
(Figure S3). Photoporation was performed with a fixed concentration of contrast agents (2 mg/ml for FD 
and 1 µM for CdSe QD), but with increasing laser fluence settings (all above the vapour nanobubble 
generation threshold of ~1 J/cm2)43. From the confocal images in Fig. 1b (END for endocytic labelling, 
VNB for vapour nanobubble photoporation labelling) the difference in intracellular labelling pattern is 
immediately clear. As expected, endocytic labelling results in a punctuate pattern due to endosomal 
sequestration of the contrast agent, while a uniform cytosolic labelling is obtained by photoporation. Image 
quantification (upper panels in Fig. 1c, d) shows that endocytic labelling results in nearly 100% of the cells 
with a detectable signal. For photoporation approximately 80% of the cells have a detectable signal at the 
lowest laser fluence of 1 J/cm2, which becomes >90% for higher fluences. The difference in efficiency 
between both labelling methods, however, becomes apparent when looking at the total signal per cell, 
expressed as the relative mean fluorescence intensity rMFI (rMFI = MFI labelled cells / MFI control cells) 
(middle panel in Fig. 1c, d). For instance, at a laser fluence of 4 J/cm2, cells labelled with FD by 
photoporation are as much as 50 times brighter as compared to endocytic labelling at the highest 
concentration tested. While the difference was less pronounced in case of CdSe QD, still a 3 times higher 
labelling intensity was found in case of photoporation. In terms of cytotoxicity (lower panels in Fig. 1c, d), 
endocytic uptake of FD did not have any effect on the cells. For photoporation the cell viability was close 
to 90% regardless of the laser fluence used. Endocytic uptake of CdSe QD resulted in a concentration 
dependent cytotoxicity. Only for the lowest concentration (100 nM) >80% cell viability was obtained. A 
similar concentration dependent toxicity was found for VNB photoporation with CdSe QD. 80% cell 
viability was obtained at an intermediate laser fluence of 2 J/cm2. Notably, the signal per cell for this 
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condition is 5 times higher as compared to endocytic labelling at the non-toxic concentration of 100 nM. 
Similar experiments were carried out for INS-1E cells, which is a type insulin producing cell under 
investigation for the treatment of type I diabetes5. As can be seen from the results in Figure S4, the findings 
on HeLa cells could be confirmed for INS-1E cells, indicating that the results are independent of the cell 
type.  
Cell labelling by photoporation enables extended cell tracking in vitro. 
So far we have shown that photoporation allows a much higher amount of label to be delivered into (the 
cytoplasm of) cells. Combined with the fact that endolysosomal degradation or quenching of the label is 
avoided when contrast agents are directly delivered to the cytoplasm, we hypothesized that those cells can 
be imaged over an extended number of cell generations as compared to cells labelled by endocytosis. In the 
following experiments, a laser fluence of 2 J/cm2 was used, for which the cell viability remains above 80% 
for both FD and CdSe QD (cfr. Fig. 1c, d). Following photoporation with the FD or CdSe QD, we monitored 
the mean fluorescence intensity (MFI) of the labelled cells over multiple generations by flow cytometry. 
The data in Fig. 2a and b show the decrease in cell intensity over time relative to the MFI at t = 0 (i.e. 
immediately after labelling). The signal decrease for the photoporated cells (Fig. 2a, b) is solely due to 
dilution of the contrast agent upon subsequent cell divisions. Indeed, with a mono-exponential fit we 
obtained a cell division time of ~25 h for HeLa cells, which is in perfect agreement with reported values47. 
To corroborate this finding, a similar test was performed on faster (C17.2 cells) and slower (INS-1E cells) 
dividing cell lines, resulting in the expected doubling times of ~17 and ~39 h, respectively (Figure S5). 
Importantly, a signal decrease that is only attributed to dilution by cell division is the best one can achieve 
for extrinsic contrast agents. Instead, cells labelled by endocytosis exhibited a much more rapid decrease of 
the cell signal (Fig. 2a, b), due to other processes than cell division alone, most importantly label 
degradation (CdSe QD) or fluorescence quenching (FD) in the acidic endolysosomes26, 28.  
To more precisely quantify the gain in long-term cell visibility of photoporated cells, we determined the 
percentage of detectable cells, i.e. cell with an intensity higher than unlabelled control cells, over multiple 
9 
 
cell generations by flow cytometry (Fig. 2c, d). Although both delivery methods resulted in more than 90% 
positive cells immediately after cell loading, the number of detectable cells quickly decreased in case of 
endocytic labelling for both FD and CdSe QD. Already after one cell division 20% of FD labelled cells 
became undetectable, and after 5 cell divisions the cells could no longer be detected. Instead, when cells 
were loaded with FD by photoporation, nearly 100% of the cells remained visible for 5 generations. Even 
after 7 divisions more than 80% of these cells were still detectable. Similar results were found for CdSe QD 
loaded cells. After one cell division only ~30% of cells labelled by endocytosis could be detected, while this 
was still >90% for photoporated cells. After three cell divisions >70% of photoporated cells could still be 
detected, while this was <10% for endocytic labelling. The main reason why FD labelled cells can be 
detected for much longer time as compared to CdSe QD labelled cells is due to a higher loading efficiency 
of FD by photoporation (cfr. Fig. 1c, d).  
Similar experiments were performed with the INS-1E cell line (Figure S6). For FD labelled cells the results 
were identical to those obtained in HeLa cells. For CdSe QD labelled cells the difference between labelling 
by endocytosis and photoporation were even more pronounced. Almost no cells could be detected after one 
generation in case of endocytic loading, likely due to the long residence time in the degradative 
endolysosomes of the slow division rate. Instead, when CdSe QDs were delivered into the cytosol by 
photoporation, it was only after eight cell divisions that the signal was lost. Taken together, we conclude 
that delivering labels into the cytosol by photoporation significantly enhances the long-term cell visibility, 
with a signal decay that is solely determined by cell division. Due to the high loading capacity we find that 
old-school FDs clearly outperform CdSe QDs for this purpose.  
Cytosolic delivery of contrast agents avoids asymmetric inheritance over daughter cells and the 
concomitant increase in cell labelling polydispersity.  
It is known that contrast agents residing in endocytic vesicles are partitioned unequally between daughter 
cells during cell division30, 37. This results in an increasingly heterogeneous population of labelled cells with 
each cell division, which confounds quantification of cell numbers in in vivo applications. We hypothesized 
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that this drawback can be countered by directly delivering contrast agents into the cell cytoplasm. For a 
quantitative comparison between endocytosis and photoporation, we selected Alexa fluro@488 labelled 
dextran (AD) and InP/ZnS core/shell quantum dots (InP QD) which should be less affected by the acidic 
and degradative environment of the endolysosomes. This is confirmed by Figure S7 showing that the signal 
decay over cell generations is only due to cell division after endocytic uptake. Hence, changes in cell 
intensity are only due to cell division, as is required for these experiments.  
In first instance, the mitotic partitioning of the intracellular fluorescent labels in individual HeLa cells was 
imaged by fluorescence microscopy for two subsequent cell divisions, with pictures being taken every hour. 
Representative images in Fig. 3a, b (also see Supporting Movie 3-6) show that the fluorescent labels are 
diluted upon each imaged cell division. The punctate pattern observed in the cells labelled by endocytosis 
(END, left panels in Fig. 3a, b) is in stark contrast with the homogenous labelling of the entire cell cytoplasm 
in photoporated cells (VNB, right panels in Fig. 3a, b). However, one can still notice a slight punctuate 
pattern on top of the homogeneous cytosolic labelling after photoporation (see Supporting Movie 4 and 6). 
This is due to a small amount of label endocytosed during the three minutes laser treatment, as confirmed 
by control experiments where cells were incubated for the three minute with AD and InP QD (Figure S8). 
After two cell divisions the asymmetric partitioning of endocytosed contrast agents over daughter cells can 
already be noticed on sight (compare for instance D11 with D12 in Fig. 3b).  
To more precisely quantify and characterize the mitotic inheritance of contrast agents in daughter cells, we 
calculated the fluorescence intensity (FI) for 155-210 mother cells and their respective daughter cells. The 
FI of the brightest daughter cell is plotted in Fig. 3c and d against the FI of the mother cell. In case of 
symmetric division, one expects each daughter cell to contain 50% of the original fluorescence. This is 
exactly what is observed for the photoporated cells, whose data show a slope of 0.515 for AD and 0.509 for 
InP QD respectively. In contrast, for cells labelled by endocytosis, the slope is 0.619 for AD and 0.605 for 
InP QD, implying that one of the daughter cells receives ~60% of the contrast agents (while the other 
receives ~40%).  
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To confirm these results, we went on to investigate statistically the inheritance of contrast agents by daughter 
cells using flow cytometry. The FI was measured immediately after labelling and after one cell division 
(respectively the grey and black lines in Fig. 3e-f). To interpret these results, we developed a statistical 
model describing the inheritance of materials over daughter cells. The model was applied to the 
experimental data to obtain the distribution that best matches the observed daughter distribution starting 
from the mother distribution. The result of the fitting is a parameter p that expresses the extent of asymmetry, 
with 0.5 indicating perfect symmetry. As expected from the microscopy data and in accordance with our 
hypothesis, for photoporated cells a p value of 0.50 and 0.51 was found for AD and InP QD, respectively. 
This result is independent of the cell type as the same observation was made in a second cell line (C17.2 
cells, Figure S9). On the contrary, an unequal distribution of endocytosed contrast agents could be 
confirmed with p values of 0.66 for AD and 0.63 for the InP QD. 
 While an asymmetric division of 40/60 may not seem substantial in the first generation, it does introduce 
tremendous polydispersity in cell intensity over multiple cell divisions. This can be seen in Fig. 4 where the 
FI distributions are shown over multiple generations for endocytic labelling (Fig. 4a) and labelling by 
photoporation (Fig. 4b). The polydispersity is plotted as a function of cell generation in Fig. 4c, clearly 
showing that it remains unchanged for cytosolic delivery but increases rapidly for endocytic uptake. 
Additionally, we applied the statistical inheritance model to the mother distributions (p = 0.51 for 
photoporation and p = 0.64 for endocytosis) and found that it accurately predicts the observed polydispersity 
trend.  
Cell labelling by photoporation enables prolonged in vivo cell imaging. 
Cell transplantation has been proposed as an attractive therapy in a multitude of pathologies. One example 
is type I diabetes, where insulin producing cells transplantation is a promising strategy to replenish insulin 
production48. In order to visualize whether the transplanted cells reach and remain at their target site, 
appropriate labelling techniques are required that enable long-term cell tracking. To confirm if the in vitro 
benefits of cell labelling by photoporation are valid in vivo, we labelled INS-1E cells with Cy5.5-dextrans 
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and InP/ZnS QD (@690nm) by photoporation and endocytosis. 1 million INS-1E cells were subcutaneously 
injected in the hind limbs of seven to nine weeks old Swiss Nude mice (left side: unlabelled control cells, 
right side: labelled cells). Fluorescence and bioluminescence images of the mice were recorded up to 55 
days post injection. The fluorescent signal from InP QD labelled cells could not be distinguished from the 
background for either labelling methods (Figure S10) due to the limited loading as compared to fluorescent 
dextrans (vide supra). In contrast, the fluorescent signal of Cy5.5-dextran labelled INS-1E cells could be 
detected immediately post transplantation (day 0) for cells labelled by both methods (Fig. 5). Over time, the 
fluorescent signal gradually decreased, which resulted in complete signal loss for the cells labelled by 
endocytosis at day ~15 post injection (Fig. 5a). Strikingly, even after 55 days post injection, vapour 
nanobubble photoporated cells remained clearly detectable (Fig. 5b). In addition, the bioluminescent signal 
remained present at the injection site, which shows that the cells remained alive during the experiment 
(Figure S11). No detectable bioluminescent signal was found in other parts of the mouse bodies, indicating 
that no substantial amounts of viable cells (> 100) migrated away from the injection site. Note that a 
gradually increasing signal intensity is visible in the 'upper left part' of the mouse, which is most likely 
coming from the spleen and may be due to Cy5.5-dextrans that have been cleared from dead or dying cells 
over the time course of the experiment (two months). Overall, we can conclude that cytosolic cell labelling 
by photoporation clearly outperforms the classical endocytosis method for long-term in vivo cell tracking. 
Due to its higher loading capacity, we furthermore find that old-school labelled dextrans are better suited 
for long-term cell imaging than the newer class of more expensive and often cytotoxic QDs. 
Discussion 
For in vivo imaging of transplanted cells, labelling with the desired contrast agents is classically performed 
via simple incubation and subsequent internalization by endocytosis. This means that the contrast agent will 
typically be sequestered in endolysosomes, which is associated with a number of potential drawbacks. 
Endocytic uptake is typically time-consuming, has limited loading capacity, may lead to quenching or 
degradation of labels with concomitant increased cytotoxicity, and results in asymmetric division over 
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daughter cells. In this work we hypothesized that these shortcomings could be largely alleviated by 
delivering contrast agents directly into the cytosol. Photoporation was chosen to this end, as it was recently 
shown by our group and others to be a fast, efficient and non-toxic method to deliver therapeutic agents into 
the cytosol of cells, independent of cell type40, 43, 45. Following adsorption of a small number of gold 
nanoparticles to the cell membrane (~8 per cell), cells receive a single ns laser pulse so as to induce transient 
membrane pores by the mechanical force of vapour nanobubbles. Exogenous labels that are supplied in the 
cell medium can then diffuse through the pores into the cytoplasm. A particular benefit of photoporation by 
vapour nanobubbles is that there is no net heat transfer to the cellular environment. This means that cells 
experience less cytotoxicity as compared to the more traditional photothermal treatment at lower laser 
intensities in which case small pores are induced by heating of the cell membrane43, 49.  
As a single ns pulse per cell is sufficient, the photoporation procedure is essentially limited by the laser 
repetition rate. The laser used in this work had a (limited) repetition rate of 20 Hz which resulted in a 
treatment time of 3 min for a single well of a 96 well plate. While this is already much faster than endocytic 
labelling, we expect that speed can be increased further in the future by at least one order of magnitude by 
switching to a picosecond laser with higher repetition rate40. 
As contrast agents can be distributed throughout the entire cytoplasm, photoporation allows much higher 
cell labelling efficiency as compared to endocytic uptake, where contrast agents are restrained to the 
endolysosomal compartments. For 10 kDa FITC-dextran we observed a 50-fold increase in cell loading 
compared to endocytosis independent of cell type. As QDs are larger (slower diffusion) and can only be 
supplied in a lower molar concentration (due to cost and toxicity), the difference in loading capacity was 
less pronounced, but photoporation was still 3 times more efficient than endocytic uptake of CdSe QD.  
When analysing the fluorescence intensity of cells labelled by endocytosis over multiple generations, we 
noticed that the signal intensity rapidly decreased for both FITC-dextran and CdSe QD labelled cells. 
Sequestration in the acidic and degradative endolysosomes results in quenching of the fluorescein label 
(which is strongly pH dependent) and degradation of the CdSe QD29. Instead, when the same labels were 
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delivered into the cytosol by photoporation, the signal decrease over multiple cell generations was only due 
to dilution in the daughter cells. Again these results were cell-independent since the same observations were 
made for three different cell types, including therapeutically relevant insulin producing INS-1E cells. In 
addition, endosomal sequestration of CdSe QD resulted in noticeable concentration-dependent toxicity, 
which could be largely avoided when delivered in the cytosol by photoporation. This is in agreement with 
a recent publication where metallic NPs were found to cause cell injury when sequestered in endosomes, 
but not when delivered straight into the cytoplasm50.  
Nanomaterials, like QDs, present in the endolysosomes are known to be distributed unevenly over daughter 
cells upon cell division30. Here we could confirm this observation and report for the first time that it is 
equally true for endocytosed molecular agents like Alexa Fluor dextran. This is perhaps not so surprising in 
light of the recent finding that asymmetric inheritance of vesicles is a naturally occurring cellular process37. 
Indeed, asymmetric cell division appears to be a crucial biological feature that does not only provide 
protection against exogenous materials, but is also involved in differentiation towards various lineages51, 52. 
Here, we hypothesized that asymmetric inheritance of contrast agents could be avoided by delivering the 
labels directly into the cell cytoplasm. In that case the labels are homogeneously distributed throughout the 
cytoplasm and there is no active mechanism that the cell can use anymore (such as motor proteins in case 
of endosomes) to shuttle the nanomaterials preferentially to one of the daughter cells. This was confirmed 
with labelling by photoporation independent of label and cell type. In contrast, in case of endocytosis, labels 
were divided over daughter cells in a 40/60 ratio. While this may not seem like a major problem on first 
sight, it does pose problems for accurate quantification of cell numbers in in vivo imaging after multiple cell 
divisions. Indeed, already after 6 generations the label polydispersity will have increased 10-fold so that it 
becomes increasingly difficult to accurately relate the detected signal to cell numbers. Instead, equal 
inheritance after cytosolic loading by photoporation ensures that the polydispersity does not increase over 
cell generations. This means that signal quantification remains equally accurate over time in long-term cell 
tracking studies, which is of major importance for instance for following-up on cell therapies. To our 
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knowledge, this is the first time that it is shown that asymmetric inheritance of exogenous materials can be 
avoided by delivering labels directly into the cytosol. 
Finally, we imaged INS-1E cells in vivo labelled by photoporation or endocytosis. Following the injection 
of labelled cells in seven to nine weeks old Swiss Nude mice, we found that cells labelled with Cy5.5-
dextran by photoporation can be imaged up to two months. Instead, cells labelled by endocytosis completely 
lost their fluorescent signal after two weeks. Due to less efficient loading with InP QD, the fluorescent signal 
from InP QD labelled cells could not be distinguished from the background for neither labelling method. 
This shows that old-school fluorescent dextrans are excellent labels for cell tracking in vivo, especially in 
combination with photoporation. Taken together, we can state that we developed a highly efficient and safe 
method to label cells that enables straightforward long term cell tracking.  
Here, photoporation was selected for the cytosolic delivery of contrast agents into live cells since it has been 
shown to enable efficient loading at high throughput and with low toxicity. Although it needs to be 
demonstrated in future research, it could be expected that similar findings on long-term visibility and 
symmetric inheritance in daughter cells may be obtained with other methods that enable cytosolic delivery 
of contrast agents. For instance, electroporation could be explored to this end, although it is typically 
associated with high cell death53 and for QD it was reported to result in marked aggregation54. Also 
molecular approaches are developed to this end where contrast agents are conjugated to ligands that – 
hopefully – can translocate the contrast agents into the cytoplasm, either directly across the cell membrane 
or across endosomal membranes after endocytic uptake. Examples are CFSE (Carboxyfluorescein 
succinimidyl ester)55, but also CPP (cell-penetrating peptide) conjugates56. Yet it is clear that such strategies 
require special development of conjugates for each type of label, apart from the fact that the efficiency may 
be very much cell-dependent. Instead, a fast and efficient method like photoporation is entirely independent 
of the type of label or cell type used, and we expect that this method will see quickly increasing applications 
for intracellular delivery in general.  
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Conclusions 
Direct cytosolic delivery of nano-sized contrast agents by photoporation opens up exciting avenues for 
improved long-term quantitative in vivo cell tracking. Apart from much more efficient cell loading and 
prolonged cell visibility in vitro and in vivo as compared to endocytic labelling, we show for the first time 
that asymmetric inheritance of labels can be avoided by delivering the labels directly into the cytosol through 
photoporation. As photoporation is independent of the cell type and contrast agent used, we expect that it 
will be a major benefit for improved long-term cell tracking studies. While this study focused on 
fluorescence labels, it will be of interest to evaluate in the future cell labelling with e.g. superparamagnetic 
iron oxide nanoparticles or Gd-complexes for magnetic resonance imaging. 
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Methods 
Materials. 520 (±10) nm CdSe/ZnS quantum dots and 690 (±25) nm InP/ZnS fluorescent nanocrystals 
coated with a thiol oligomer, surface functionalized with -COOH groups (PEG-coated QD) were purchased 
from Mesolight, Inc. (#CdSe/ZnS-PEG-COOH-520 and #InP/ZnS-PEG-COOH-690, Mesolight, Inc., Little 
Rock Arkansas, USA). 520 (+/-15) InP/ZnS nm QD, functionalized with -COOH groups, were purchased 
from AC Diagnostics, Inc. (#CAIPS-520-P-1, AC Diagnostics, Inc., Fayetteville, AR, USA). 70 nm cationic 
AuNPs were purchased from NanoPartz (#CU11-70-P30-50, Nanopartz Inc., Loveland, CO, USA). These 
AuNPs had a zeta potential of 30 mV as measured by dynamic light scattering (NanoSizer, Malvern, UK). 
FITC-dextrans (FD) with a molecular weight of 10 kDa were purchased from Sigma-Aldrich (Belgium). 
Alexa Fluor @488 labelled 10 kDa dextrans (AD) (#D-22910, Molecular Probes®), Propidium Iodide 
(#P1304MP, Molecular Probes®) and Hoechst (cell nuclei labelling, #H3570, Molecular Probes®) were 
obtained from Invitrogen (Belgium). Cy5.5 labelled 10 kDa dextrans (CD) were purchased from Interchim 
(#FP-DZ2581, France). 
Cell culture. Three different cell lines were applied in this work, namely the HeLa, C17.2 and INS-1E cell 
line. HeLa cells were obtained from ATCC (CCL-2) and cultured in complete cell medium which consisted 
of DMEM/F-12 supplemented with 10% heat-inactivated foetal bovine serum (FBS), 2 mM glutamine and 
100 U/mL penicillin/streptomycin. The C17.2 neural progenitor cell line was retrieved from Sigma 
(Belgium) and cultured in DMEM containing 10% FBS, 5% horse serum, 2mM L-Glutamine and 100 U/mL 
penicillin/streptomycin. Finally, the LV-transduced INS-1E cells were cultured in RPMI completed with 
10% FBS, 2mM L-Glutamine, 100 U/mL penicillin/streptomycin, 1% 100mM sodium pyruvate, 0.1% 
50mM 2-mercaptoethanol and 10 mM Hepes. All cells were cultured at 37°C in a humid atmosphere 
containing 5% CO2. All cell culture products were obtained from Invitrogen (Belgium) unless specifically 
stated otherwise. 
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Detection of AuNPs by confocal reflectance imaging and TEM. HeLa cells were cultured as described 
above. Cells were incubated with AuNPs for 30 min at 37°C at a fixed concentration of ~5×107 particles/ml. 
Cells were washed to remove unbound AuNPs. For confocal imaging the plasma membrane was stained 
with red fluorescent CellMask (#C10046, ThermoFisher Scientific). Confocal images were acquired with a 
Nikon C1si confocal laser scanning microscope using a 60× oil lens with 1.4 numerical aperture. AuNP 
were detected by the reflected laser light and false-colored in green. For TEM imaging, cell sections were 
placed on carbon-coated Cu grids (200-mesh) and visualized by a JEM 1400plus transmission electron 
microscope (JEOL, Tokyo, Japan) operating at 60 kV.  
Generation and detection of vapour nanobubble. A homemade setup, including an optical and electrical 
timing system, was used to generate and detect the vapour nanobubble37. A pulsed laser (~7 ns) tuned at a 
wavelength of 561 nm (OpoletteTM HE 355 LD, OPOTEK Inc., Faraday Ave, CA, USA) was applied to 
illuminate the AuNPs in order to generate vapour nanobubbles. Under these conditions the initial AuNP 
temperature will be in the order of 500 K upon absorption of a single laser pulse. Here we have taken into 
account that only the first 0.5 ns of the laser pulse is most efficiently absorbed since after that there is efflux 
of heat energy to form the vapour nanobubble and the emerging nanobubble scatters (partly) the 
subsequently incoming light. For a more detailed theoretical framework the reader is referred to the work 
by  Pustovalov et al.42. Finally, the setup has a time-response and light scattering mode to allow detection 
of VNB formation43.  
Cell labelling via endocytosis. HeLa and C17.2 cells were seeded in 96 well plates at a density of 15000 
cells/well while for INS-1E cells a density of 100000 cells/well was respected. Cells were allowed to settle 
overnight prior to treatment. Typically, for endocytosis experiments the cells were incubated with 2 mg/ml 
FITC-dextrans (FD) / Alexa@488-dextran (AD) / Cy5.5-dextran (CD) or 400 nM QDs (CdSe/ZnS @ 520 
nm, InP/ZnS @ 520 nm, InP/ZnS @ 690 nm) during 1 hour at 37°C. In viability experiments also 100 and 
200 nM QD dispersions were included. Subsequently cells were washed once with PBS (Invitrogen, 
Belgium) before performing further analysis.  
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Cell labelling via vapour nanobubble photoporation. For laser treatment, the cells were seeded at the 
same densities as for endocytic cell loading. Here, cells were initially incubated with AuNPs during 30 min 
at 37°C at a fixed concentration of ~5×107 particles/mL for HeLa and C17.2 cells and ~1×108 particles/mL 
for the INS-1E cells. Next, the cells were washed to remove remaining free AuNPs and a 2 mg/ml dextran 
dispersion (FD, AD or CD), or 1 µM QD dispersion (CdSe/ZnS @ 520 nm, InP/ZnS @ 520 nm or InP/ZnS 
@ 690 nm) was added just prior to the laser scanning. After the laser treatment, the cells were washed once 
with PBS and supplied with fresh cell medium before continuing with further analysis.  
Measuring fluorescence intensity (FI) by fluorescence microscopy. Cells were imaged in a stage-top cell 
incubator (37°C with 5% CO2 supplied, Tokai heat) for ~ 48 hours using a swept field confocal microscope 
(SFC & Eclipse Ti, Nikon, Japan). Each hour, cells were imaged with a 60× oil immersion lens (CFI Plan 
Apo VC 60×oil, Nikon, Japan) over a large area by stitching 25 by 25 images, thus covering ~2.15 mm by 
~2.15 mm with ~1500 cells. The microscope’s autofocus system was used to maintain a constant focus 
position on the cells. ImageJ software was used to segment the cells and calculate the fluorescence of each 
cell. The FI of each cell was calculated as follows: 
ܨܫ ൌ ሺܨܫ௖௘௟௟ െ ܨܫ஻ீሻ ൈ 	ߚ	ሺ1ሻ 
where ܨܫ௖௘௟௟  is the total fluorescence intensity of a cell as measured by ImageJ, and ܨܫ஻ீ  is the total 
background fluorescence intensity within the area of one cell. β used to compensate for photobleaching and 
was defined as ߚ ൌ ܫ଴̅/ܫ௜̅  where ܫ଴̅  is the initial average fluorescence intensity and ܫ௜̅  is the average 
fluorescence intensity after i times of laser scanning. 
Measuring mean fluorescence intensity (MFI) by flow cytometry. Following labelling with either 
fluorescently labelled dextrans or QD via endocytosis or photoporation, cells were detached by trypsin-
EDTA (Invitrogen, Belgium) treatment and collected by centrifugation. Following resuspension in flow 
buffer (PBS supplemented with 5% FBS) the samples were measured by flow cytometry (FACS Calibur, 
BD, Belgium) and 10000 events were detected per sample. The cells were excited with a 488 nm laser and 
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fluorescence was recorded in the 530/30 channel. For a certain time ti after labelling, the normalized 
ܯܨܫതതതതതത௧೔was obtained by normalizing the population MFI (ܯܨܫ௧೔ ) to the MFI of cells immediately after 
labelling (ܯܨܫ௧బ):  
ܯܨܫതതതതതത௧೔ ൌ
ܯܨܫ௧೔ െ ܯܨܫ௧೔௖௧௥௟
ܯܨܫ௧బ െ ܯܨܫ௧బ௖௧௥௟
	ሺ2ሻ 
where ܯܨܫ௧೔௖௧௥௟  is the MFI of untreated cells (i.e. correction for contribution by autofluorescence). The 
following mono-exponential decay model was used to obtain the cell division time τ: 
ܯܨܫതതതതതത ൌ 2ିሺ௧ఛሻ	ሺ3ሻ 
Finally, the relative MFI of a cell population was calculated by dividing the MFI at a certain time after 
labelling by the MFI of untreated cells at the same time point.  
Evaluation of cell viability following cell labelling. Cells were seeded and loaded according to methods 
described above. Subsequently, cells were washed once with PBS, fresh medium was added and cells were 
allowed to recover two hours before performing the MTT assay. To this end 30 µl of a 5 mg/ml 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, Belgium) solution was added to each 
well. Following an incubation period of three hours at 37°C the MTT containing cell medium was removed 
and cells were lysed using dimethylsulfoxide (Sigma, Belgium). When the formazan crystals were 
completely dissolved, the absorbance in each well was measured at 570 and 650 nm using an Envision Xcite 
multilabel reader (PerkinElmer LAS, Boston, MA). NP containing cell medium was included as a control 
to allow correction for the possible interaction of the NPs with the assay. Additionally, we evaluated cell 
viability following vapour nanobubble generation without contrast agent loading. In this way we could 
differentiate to what extent effects on viability were stemming from the loading method. All data are 
expressed as the mean ± SD (n=3).  
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Statistical model to describe the inheritance of contrast agents over subsequent cell generations. As 
reported previously, the redistribution of endocytosed NPs over daughter cells can be modelled by a 
convolution product of the original cell distribution with a binomial partitioning probability function30: 
݊௧భሺ ଵܰሻ ൌ ෍݊௧బሺܰሻ ൈ ܶሺܰ, ଵܰሻ
ே
		ሺ4ሻ 
ܶሺܰ, ଵܰሻ ൌ ሺ1 െ ݂ሻߜሺ ଵܰ ൌ ܰሻ ൅ ݂ሾܾ݅݊݋݈݉݅ܽሺܰ, ଵܰ, ݌ሻ ൅ ܾ݅݊݋݈݉݅ܽሺܰ, ܰ െ ଵܰ, ݌ሻሿ	ሺ5ሻ 
Here, T is the transfer function and includes two binomial functions, describing the probability of N1 endo-
lysosomal vesicles containing NPs being inherited by one of the daughter cells upon division of the mother 
cell with N vesicles. Parameter p describes the probability of endolysosomal vesicles being allocated to a 
specific daughter cell during division. p = 0.5 signifies 50% chance that the daughter cell will receive the 
vesicle, while p = 1 means that all of the vesicles will be inherited by the daughter cell. While this model 
was developed for describing the repartitioning of a small number of NP containing endolysosomal vesicles 
(typically<100), in our work we are dealing with much higher numbers (typically >105 particles). When the 
statistical samples are large enough (typically N>100), the binomial distribution can be approximated by a 
normal distribution. This means that the convolution probability distribution can be approximated by a 
normal distribution. Similarly, the fluorescence intensity distributions of daughter cells can be convoluted 
by the transfer function implemented with a normal probability function:  
ܨሺܫଵሻ ൌ෍ܨ௧బሺܫሻ ൈ ܶሺܫ, ܫଵሻ
ூ
		ሺ6ሻ 
Here, I is the fluorescence intensity of a mother cell and I1 is the fluorescence intensity inherited by one of 
the daughter cells after cell division. The transfer function T (I, I1) can be expressed with two normal 
distribution functions which describe the probability that a mother cell with intensity I transfers its contrast 
agents over its daughter cells in a ratio I1/I-I1: 
ܶሺܫ, ܫଵሻ ൌ ሺ1 െ ݂ሻߜሺܫଵ ൌ ܫ െ ܫଵሻ ൅ ݂ሾܰሺܫଵ, ߤଵ, ߪሻ ൅ ܰሺܫଵ, ߤଶ, ߪሻሿ	ሺ7ሻ 
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Here, f is the fraction of cells that have undergone mitosis and N is the normal distribution function. 
 
ܰሺܫଵ, ߤ௜, ߪሻ ൌ 1ߪ√2ߨ exp ቈെ
ሺܫଵ െ ߤ௜ሻଶ
2ߪଶ ቉	ሺ8ሻ 
 
The mean µ1 and µ2, and the standard deviation σ are defined as 
ߤଵ ൌ ܫ ∙ ݌, ߤଶ ൌ ܫ ∙ ሺ1 െ ݌	ሻ, ߪ ൌ ඥܫ ∙ ݌ ∙ ሺ1 െ ݌	ሻ		ሺ9ሻ 
where p is the probability that a contrast agent is inherent by one particular daughter cell upon cell 
division and I is the mother cell fluorescence intensity.  
In vivo experiments long-term cell tracking post injection in mice. All animal experiments were executed 
in accordance with national and European regulations and approved by the local Animal Ethics Committee. 
Swiss Nude mice (7-9 weeks old, Charles River, Chatillon-sur-Chalaronne, France) received 1 million LV-
transduced (fLuc expression for bioluminescence) INS-1E cells suspended in 100 µL cell culture medium 
subcutaneously into both the hind limbs (left side: unlabelled control cells; right side: labelled cells). During 
cell transplantation, animals were anesthetized with 2% isoflurane (Isoflurane ISP, Rothacher, Basel, 
Switzerland) in 100% oxygen, at a flow rate of 2 L/minute. For both in vivo bioluminescence imaging (BLI) 
and fluorescent imaging (FLI), the animals were anesthetized with 2% isoflurane in 100% oxygen, at a flow 
rate of 2 L/minute. All the images were acquired using an IVIS in vivo optical imaging system (PerkinElmer, 
Massachusetts, U.S.A). For the BLI, D-luciferin, dissolved in PBS (15 mg/mL), was injected 
intraperitoneally (126 mg/kg body weight) prior to the imaging sessions. Consecutive frames were acquired 
each minute until the maximum signal intensity was reached. For the FLI acquisition, the EPI mode was 
used with an excitation wavelength at 673 nm and an emission wavelength at 707 nm for Cy5.5 according 
to its default value set in the system software (Living Imaging, Perkin Elmer). All reported BLI and FLI 
images were superimposed by a grey-scale photographic image with anatomical information and a 
pseudocolor image with functional/optical information. The BLI/FLI signals were expressed as total photon 
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flux (p/s/sr) from circular region of interests (ROI) using the Living Imaging software. The FLI signals of 
average radiance were also quantified in the ROI by this software (Perkin Elmer). No samples or animals 
were excluded from the analysis. The quantification data are expressed in average radiance of FLI or BLI 
with the mean ± SD (n=3). The data was compared by one-way ANOVA.  
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Figure legends 
Figure 1. Cell labelling by photoporation vs. endocytic uptake of contrast agents. a, Schematic 
overview of the experimental procedure to label cells by photoporation. b, Confocal images show successful 
cell labelling with FD and CdSe QD by endocytic uptake (END) and photoporation (VNB). Control images 
are shown for cells incubated with FD and CdSe QD, which received laser treatment without AuNPs and 
VNB formation. This shows that photoporation is not induced by the laser irradiation alone. c-d, 
Quantification of the percentage of positive cells (yellow), the labelling intensity per cell (cyan) and cell 
viability (magenta) as a function of label concentration in case of endocytic labelling and as a function of 
laser fluence from 1 to 4 J/cm2 for photoporation. The cell viability is also shown for cells treated with 
photoporation but without addition of contrast agents, showing that the photoporation procedure in itself 
induces very little toxicity. (n=3) 
Figure 2. Long-term visibility of HeLa cells labelled by photoporation vs. endocytic labelling. a-b, The 
normalized MFI is shown in function of time after labelling for cells loaded with FD (a) and CdSe QD (b) 
via both photoporation (VNB, orange squares in a and b) and endocytic labelling (END, black circles in a 
and b). Each data point belongs to one of three independent biological repeats; each data point is the average 
of three technical repeats. A mono-exponential decay function was fitted to the photoporation data to 
calculate the mean cell division time (orange lines in a and b).  c-d, The percentage of detectable cells is 
shown over several cell generations for respectively FD (c) and CdSe QD (d) labelled cells. Endocytic 
labelling (END, grey bars in c and d) is compared with cell labelling via photoporation (VNB, orange bars 
in c and d). (n=3) 
Figure 3. Inheritance of contrast agents in cells labelled by endocytosis or photoporation. a-b, 
Representative confocal time-lapse images show the redistribution of contrast agents (AD and InP QD) over 
daughter cells after two subsequent cell divisions. Endocytosed contrast agents are located inside endosomes 
(punctuate pattern) and are unequally partitioned over daughter cells, e.g. compare D11 and D12 of InP QD 
labelled cells (END, left panels in a and b). Photoporation results in uniform cytoplasmic labelling and 
equal distribution of the contrast agents over daughter cells (VNB, right panels in a and b). c-d, Based on 
image quantification of confocal time lapse images, the fluorescence intensity (FI) of mother cells (n=210 
for AD-END, n=205 for AD-VNB, n=172 for InP QD-END, n=155 for InP QD-VNB) is plotted against the 
FI of their brightest daughter cell. Linear regression shows a slope of ~0.5 for photoporated cells (equal 
redistribution) and ~0.6 for cells labelled by endocytosis (unequal redistribution). e-f, Flow cytometry was 
used to quantify the FI of cells immediately after labelling (grey line) and after one cell division (black line). 
A statistical inheritance model was fitted to the data (orange line) confirming equal inheritance (p = 0.50-
0.51) in case of photoporated cells (VNB, right panels in e and f) as opposed to cells labelled by endocytosis 
(p = 0.63-0.66) (END, left panels in e and f).  
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Figure 4. Asymmetric inheritance, leading to highly heterogeneous cell labelling over multiple 
generations, can be avoided by photoporation. a-b, Distributions of the cell fluorescence intensity (FI) is 
shown over multiple cell generations (G0-G7) for cells labelled with AD by endocytosis (END) (a) and 
photoporation (VNB) (b). As for endocytosis the intensity is close to the background after 3 divisions, the 
statistical inheritance model was applied (p = 0.64) to the mother distribution (G0) to simulate the 
distributions for G4 and G7 (dashed lines). c, The polydispersity ܲܦܫ ൌ ሺߪ/ܫሻ̅ଶ of the distributions remains 
the same in case of cells labelled by photoporation, while it rapidly increases in case of endocytic labelling. 
The data is well predicted by the statistical inheritance model with p = 0.64 for endocytosis and p = 0.51 for 
photoporation. 
Figure 5. Long term in vivo imaging of transplanted INS-1E cells labelled by either photoporation or 
endocytosis. INS-1E cells were labelled with Cy5.5-dextran (CD) by (a) endocytic uptake (END) or (b) 
photoporation (VNB). Labelled cells were subcutaneously injected right hind limb of Swiss Nude mice. 
Unlabelled control cells were injected at left side. For three independent repeats, the fluorescence was 
quantified over time of labelled (orange) and unlabelled (green) cells in the indicated regions of interest 
(ROI). Photoporated cells were still clearly visible after 55 days, as opposed to cells labelled by endocytosis 
which disappeared already after 15 days. 
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